| Accession Number: | 0001179110-21-004097 |
| Date: | 2021-03-31 |
| Issuer: | ABIOMED INC (ABMD) |
| Original Submission Date: |
GREENFIELD ANDREW J
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS, MA 01923
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, $.01 PAR VALUE | 2021-03-31 | A | 30 | a | $0.00 | 36,960 | direct | ||
| COMMON STOCK, $.01 PAR VALUE | 2021-03-31 | 0 | $0.00 | 12,032 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 99.62 | 2021-03-31 | deemed execution date | 0 ( ) | 2017-05-24 | 2026-05-24 | common stock 0 | $99.62 | 5,000 | direct | ||
| STOCK OPTION (RIGHT TO BUY) | 134.51 | 2021-03-31 | deemed execution date | 0 ( ) | 2018-05-15 | 2027-05-15 | common stock 0 | $134.51 | 6,500 | direct | ||
| STOCK OPTION (RIGHT TO BUY) | 381.97 | 2021-03-31 | deemed execution date | 0 ( ) | 2019-05-16 | 2028-05-16 | common stock 0 | $381.97 | 4,000 | direct | ||
| STOCK OPTION (RIGHT TO BUY) | 266.39 | 2021-03-31 | deemed execution date | 0 ( ) | 2020-05-30 | 2029-05-30 | common stock 0 | $266.39 | 7,000 | direct | ||
| STOCK OPTION (RIGHT TO BUY | 223.9 | 2021-03-31 | deemed execution date | 0 ( ) | 2021-05-29 | 2030-05-29 | common stock 0 | $223.90 | 4,896 | direct |
| ID | footnote |
|---|---|
| f1 | these options become exercisable in annual 33-1/3% increments, commencing on the date shown in table ii, column 6. |
| f2 | grant to reporting person of option to buy the number of shares of common stock set forth in table ii, column 7, under the abiomed, inc. 2015 omnibus incentive plan. |
| f3 | these shares of common stock were acquired by the reporting person through participation in the abiomed, inc. employee stock purchase plan, qualified under section 423 of the internal revenue code, and the transaction was exempt under rule 16b-3(c). |
